Jame Abraham, MD, FACP
Jame Abraham, MD, FACP, has been appointed the new Chair of the Hematology/Medical Oncology Department at Cleveland Clinic. In this capacity, he will recruit and develop staff as well as guide the department’s focus on patient access and a multidisciplinary approach to care. Dr. Abraham currently serves as Director of the Breast Oncology Program at Taussig Cancer Institute and Co-Director of the Cleveland Clinic Comprehensive Breast Cancer Program. He is also Professor of Medicine at Cleveland Clinic Lerner College of Medicine.
Dr. Abraham is a member of the National Comprehensive Cancer Network Breast Cancer Committee, Vice Chair of the Research Strategy Committee of NRG Oncology, and a member of the Breast Cancer Working Committee for NRG Oncology. He also is Vice Chair of the Research Review Committee for the National Surgical Adjuvant Breast and Bowel Project.
As the national principal investigator of multiple breast cancer clinical trials, Dr. Abraham has published and presented more than 200 papers. He is also the Founding Editor of The Bethesda Handbook of Clinical Oncology and an Associate Editor of The ASCO Post.
Brian Bolwell, MD
“Successfully leading our Hematology/Medical Oncology Department requires a leader who excels at empathy, fosters a culture of teamwork, demonstrates emotional intelligence and believes in the vision of our institute,” said Brian Bolwell, MD, Chairman of Taussig Cancer Institute. “Dr. Abraham represents these qualities and has exhibited a passion for department and caregiver development, and elevating our national reputation.”
Dr. Abraham completed his residency at the University of Connecticut School of Medicine, followed by a medical oncology fellowship at the National Cancer Institute and a hematology fellowship at the National Heart, Lung, and Blood Institute of the National Institutes of Health. He earned his medical degree from Calicut Medical College in Kerala, India. ■
